Literature DB >> 8558025

Immune or normal gamma delta T cells that assist alpha beta T cells in elicitation of contact sensitivity preferentially use V gamma 5 and V delta 4 variable region gene segments.

W Ptak1, M Szczepanik, R Ramabhadran, P W Askenase.   

Abstract

In the current study, we confirmed previous findings suggesting that gamma delta T cells were involved in the successful adoptive cell transfer of contact sensitivity (CS) by alpha beta CS-effector T cells. In this study, we used hamster anti-mouse gamma delta-TCR mAb treatment of CS-effector T cells, followed by enrichment and removal of the gamma delta T cells with goat anti-hamster Ig-linked magnetic beads, or by addition of hemolytic rabbit C. This removal of gamma delta T cells abrogated adoptive cell transfers of CS, despite the presence of alpha beta T cells that are known to mediate CS. FACS analysis documented enrichment of gamma delta T cells rising from 1 to 2% of the starting cells, to 60 to 95% of the magnetic bead adherent cells. Adoptive cell transfer of CS was reconstituted by adding back to the alpha beta cells, highly enriched gamma delta cells attached to anti-gamma delta-TCR magnetic beads. Not only were gamma delta-enriched T cells from sensitized mice able to assist immune CS-effector alpha beta T cells, but gamma delta T cells from normal nonimmune mice also had CS-assisting activity, and furthermore, neither were MHC-restricted in this function. Thus, CS-assisting gamma delta T cells were present endogenously in normal mice without prior immunization, and acted without Ag specificity and without MHC restriction, to assist CS-effector alpha beta T cells. Similar studies, with hamster mAbs specific for V gamma and V delta portions of gamma delta-TCR, demonstrated that the gamma delta T cells that assisted the CS-effector alpha beta T cells preferentially expressed V gamma 5 and V delta 4 in their TCR. PCR analysis on extracted mRNA showed that V gamma 5 and V delta 4 gene segments indeed were rearranged and expressed in the sensitized and normal lymph nodes; and one-and two-color FACS analysis of magnetic bead-fractionated cells suggested that V gamma 5 and V delta 4 were expressed on the same T cells. In summary, these results demonstrated that V gamma 5+, V delta 4+, gamma delta T cells were needed to assist alpha beta effector T cells in the adoptive cell transfer of CS.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8558025

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  6 in total

Review 1.  Yes T cells, but three different T cells (alphabeta, gammadelta and NK T cells), and also B-1 cells mediate contact sensitivity.

Authors:  P W Askenase
Journal:  Clin Exp Immunol       Date:  2001-09       Impact factor: 4.330

2.  Cross-talk between gammadelta T lymphocytes and immune cells in humoral response.

Authors:  M Szczepanik; B Nowak; P W Askenase; W Ptak
Journal:  Immunology       Date:  1998-12       Impact factor: 7.397

3.  Impaired contact hypersensitivity to trinitrochlorobenzene in interleukin-4-deficient mice.

Authors:  F Dieli; G Sireci; E Scirè; A Salerno; A Bellavia
Journal:  Immunology       Date:  1999-09       Impact factor: 7.397

4.  Role of interleukin-4 in down-regulation of contact sensitivity by gammadelta T cells from tolerized T-cell receptor alpha-/- mice.

Authors:  M Szczepanik; W Ptak; P W Askenase
Journal:  Immunology       Date:  1999-09       Impact factor: 7.397

5.  Cross-talk between V beta 8+ and gamma delta+ T lymphocytes in contact sensitivity.

Authors:  F Dieli; W Ptak; G Sireci; G C Romano; M Potestio; A Salerno; G L Asherson
Journal:  Immunology       Date:  1998-04       Impact factor: 7.397

6.  Gamma delta T cells from tolerized alpha beta T cell receptor (TCR)-deficient mice inhibit contact sensitivity-effector T cells in vivo, and their interferon-gamma production in vitro.

Authors:  M Szczepanik; L R Anderson; H Ushio; W Ptak; M J Owen; A C Hayday; P W Askenase
Journal:  J Exp Med       Date:  1996-12-01       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.